日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Novo Nordisk sees ample room for further expansion in nation

By LIU ZHIHUA | China Daily | Updated: 2021-06-08 09:14
Share
Share - WeChat
Employees work on the production line of a Novo Nordisk venture in Tianjin. [Provided to China Daily]

China's sustained efforts to improve the business environment and encourage innovation will boost its long-term growth prospects and create ample expansion opportunities for foreign businesses, according to a senior pharmaceutical company official.

Lars Fruergaard Jorgensen, president and CEO of Denmark-based biopharmaceutical company Novo Nordisk, said he was confident about long-term growth in the country.

"We are fully confident that the Chinese economy will maintain growth. The 14th Five-Year Plan (2021-25) will serve as a roadmap for economic and social development and help sustain high-quality growth. With a supportive business environment, we are confident that Novo Nordisk, along with other foreign businesses, will enjoy long-term success in the country."

Novo Nordisk, a global leader in diabetes care, will continue to invest in a sustainable and innovation-based healthcare ecosystem in China, he said.

As China enters a new development phase featuring the dual-circulation development paradigm, which takes the domestic market as the mainstay while letting domestic and foreign markets reinforce each other, there will be significant opportunities for the company to continue enhancing its presence across the whole value chain and strengthen innovation and production capabilities to fulfill the growing needs of people with diabetes in China and globally, said Jorgensen.

China's strong economic recovery since COVID-19 is impressive, said Jorgensen, adding that Novo Nordisk's unit in the country gained significantly due to the robust domestic demand.

China has been leaving no stone unturned to deepen reforms, pursue higher-level opening-up and improve business environment, as part of its broader push to ensure high-quality development. Thanks to its robust economic performance and continuously improving business environment, foreign investors' enthusiasm in the country has been increasing steadily, experts said.

According to a recent survey conducted by the Ministry of Commerce, 96.4 percent of the more than 3,200 surveyed foreign-invested companies had a positive attitude toward future business prospects in China, up 2.1 percentage points from the beginning of this year.

Data from the ministry showed that China's actual use of foreign investment during the January-April period rose 38.6 percent on a yearly basis to 397.07 billion yuan ($62.27 billion). The total FDI value grew by 30.1 percent over the same period in 2019.

In the healthcare sector, a series of major policy reforms have been introduced since 2015, to encourage innovation, speed up new drug registration, and enhance the dynamic adjustment mechanism for the national reimbursement drug list, so as to improve quality healthcare accessibility and affordability.

According to the 14th Five-Year Plan and long-range objectives through 2035, China will continue to improve the fast-track review and approval mechanism for innovative medicines, vaccines and medical devices, so as to accelerate review and approval of medicines and medical devices for urgent clinical use and rare disease treatment.

Novo Nordisk has already established a full value chain in the country, with one of its biggest manufacturing bases in Tianjin that supplies both Chinese and international markets with durable devices for insulin injection and insulin products.

With its China Essentials program launched and updated in 2020, the company has integrated China into its latest global clinical development, aiming to achieve simultaneous submission for global new drug applications in the country.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 国产一区在线播放 | 天天爽夜夜爽夜夜爽 | 日韩av在线中文字幕 | 亚洲精品不卡 | 成人无码髙潮喷水A片 | 色午夜影院 | 黄在线观看在线播放720p | 26uuu最新地址| 日本a毛片 | 国产欧美一区二区久久 | 亚洲天堂三级 | 一区二区三区日韩在线观看 | 成人深夜福利视频 | 国产成人精品免费视频大全可播放的 | 久久精品一区 | 一级视频在线 | 日韩在线观看视频一区 | 成人免费看片视频 | 久久亚洲欧美成人精品 | 久久国产精品一区二区 | 久久激情小视频 | 99久久99久久免费精品蜜桃 | 五月婷婷婷婷 | 三级视频在线播放 | 99影视在线视频免费观看 | 亚洲精品一区二区三区四区高清 | 午夜影院在线免费观看 | 欧美日韩国产一区二区三区不卡 | 精品国产黄a∨片高清在线 亚洲3atv精品一区二区三区 | 国产精品久久久精品 | 日韩精品一区二区在线 | 国产精品毛片无码 | 欧美色性| 免费看那种视频 | 久草在线资源视频 | 欧美精品午夜久久久伊人 | 日韩黄色一级大片 | 久久精品桃花综合 | 成人亚洲 | 欧美亚洲一区二区三区 | 欧美日韩亚洲视频 |